PSMA617
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PSMA617, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT [Phase 2]